Investment Thesis
Beyond Air demonstrates exceptional revenue growth (2434% YoY) and improving loss metrics, indicating early commercial traction in medical devices. However, the company exhibits fundamental financial distress: negative operating cash flow of -$18.1M, unsustainable gross margins of 3.3%, and a 3.53x debt-to-equity ratio with negative interest coverage, indicating inability to service debt from operations. At the current -$19.2M free cash flow burn rate, cash runway is approximately 4-5 quarters without additional capital raises.
Strengths
- Explosive revenue growth of 2434% year-over-year demonstrates strong market adoption and commercial validation
- Improving loss trajectory with net loss down 3.2% YoY and EPS improving 70.9% YoY suggests operational leverage emerging
- Strong liquidity ratios (3.80x current, 3.59x quick) with $6.7M cash position provides near-term financial flexibility
Risks
- Negative free cash flow of -$19.2M is unsustainable; company burns cash faster than generates from operations
- Critically low gross margin of 3.3% and operating margin of -378.2% indicate product economics or cost structure issues requiring resolution
- High financial leverage (3.53x debt-to-equity, 21.6M long-term debt) combined with -10.0x interest coverage means company cannot service debt from operations and faces refinancing risk
Key Metrics to Watch
- Gross margin expansion trajectory and path to breakeven contribution margin
- Operating cash flow inflection point and timeline to positive operating cash generation
- Cash runway duration and need for capital raise or debt restructuring given -$19.2M annual FCF burn
Financial Metrics
Revenue
7.7M
Net Income
-33.2M
EPS (Diluted)
$-4.01
Free Cash Flow
-19.2M
Total Assets
35.4M
Cash
6.7M
Profitability Ratios
Gross Margin
3.3%
Operating Margin
-378.2%
Net Margin
-433.0%
ROE
-542.8%
ROA
-94.0%
FCF Margin
-249.6%
Balance Sheet & Liquidity
Current Ratio
3.80x
Quick Ratio
3.59x
Debt/Equity
3.53x
Debt/Assets
82.5%
Interest Coverage
-9.97x
Long-term Debt
21.6M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-07-28T06:02:18.119134 |
Data as of: 2026-12-31 |
Powered by Claude AI